科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/08/27 | 1,135 | 1,138 | 1,129 | 1,130 | +1 | +0.1% | 125,000 |
2012/08/24 | 1,127 | 1,131 | 1,123 | 1,129 | +2 | +0.2% | 160,000 |
2012/08/23 | 1,128 | 1,130 | 1,121 | 1,127 | +4 | +0.4% | 257,000 |
2012/08/22 | 1,116 | 1,125 | 1,110 | 1,123 | +7 | +0.6% | 199,000 |
2012/08/21 | 1,114 | 1,127 | 1,114 | 1,116 | +5 | +0.5% | 217,000 |
2012/08/20 | 1,109 | 1,119 | 1,108 | 1,111 | -4 | -0.4% | 182,000 |
2012/08/17 | 1,125 | 1,127 | 1,111 | 1,115 | -5 | -0.4% | 259,000 |
2012/08/16 | 1,126 | 1,132 | 1,117 | 1,120 | -6 | -0.5% | 238,000 |
2012/08/15 | 1,126 | 1,127 | 1,120 | 1,126 | ±0 | ±0% | 60,000 |
2012/08/14 | 1,107 | 1,129 | 1,105 | 1,126 | +19 | +1.7% | 175,000 |
2012/08/13 | 1,107 | 1,114 | 1,106 | 1,107 | -4 | -0.4% | 117,000 |
2012/08/10 | 1,114 | 1,117 | 1,103 | 1,111 | -3 | -0.3% | 130,000 |
2012/08/09 | 1,110 | 1,117 | 1,101 | 1,114 | +11 | +1% | 324,000 |
2012/08/08 | 1,104 | 1,111 | 1,099 | 1,103 | +3 | +0.3% | 244,000 |
2012/08/07 | 1,096 | 1,105 | 1,091 | 1,100 | +4 | +0.4% | 275,000 |
2012/08/06 | 1,080 | 1,097 | 1,079 | 1,096 | +19 | +1.8% | 227,000 |
2012/08/03 | 1,110 | 1,118 | 1,076 | 1,077 | -48 | -4.3% | 251,000 |
2012/08/02 | 1,113 | 1,132 | 1,113 | 1,125 | +12 | +1.1% | 242,000 |
2012/08/01 | 1,101 | 1,114 | 1,101 | 1,113 | +2 | +0.2% | 182,000 |
2012/07/31 | 1,110 | 1,118 | 1,105 | 1,111 | ±0 | ±0% | 151,000 |
2012/07/30 | 1,105 | 1,111 | 1,096 | 1,111 | +9 | +0.8% | 132,000 |
2012/07/27 | 1,113 | 1,114 | 1,098 | 1,102 | -10 | -0.9% | 78,000 |
2012/07/26 | 1,113 | 1,114 | 1,096 | 1,112 | +6 | +0.5% | 238,000 |
2012/07/25 | 1,101 | 1,117 | 1,096 | 1,106 | +1 | +0.1% | 202,000 |
2012/07/24 | 1,110 | 1,117 | 1,101 | 1,105 | ±0 | ±0% | 303,000 |
2012/07/23 | 1,111 | 1,124 | 1,105 | 1,105 | -17 | -1.5% | 179,000 |
2012/07/20 | 1,148 | 1,148 | 1,120 | 1,122 | -25 | -2.2% | 262,000 |
2012/07/19 | 1,140 | 1,148 | 1,135 | 1,147 | +14 | +1.2% | 213,000 |
2012/07/18 | 1,140 | 1,148 | 1,129 | 1,133 | ±0 | ±0% | 264,000 |
2012/07/17 | 1,129 | 1,138 | 1,125 | 1,133 | +4 | +0.4% | 245,000 |
2012/07/13 | 1,121 | 1,135 | 1,121 | 1,129 | +9 | +0.8% | 208,000 |
2012/07/12 | 1,116 | 1,126 | 1,111 | 1,120 | +2 | +0.2% | 193,000 |
2012/07/11 | 1,132 | 1,132 | 1,112 | 1,118 | -11 | -1% | 314,000 |
2012/07/10 | 1,120 | 1,131 | 1,116 | 1,129 | +10 | +0.9% | 266,000 |
2012/07/09 | 1,102 | 1,121 | 1,102 | 1,119 | +12 | +1.1% | 133,000 |
2012/07/06 | 1,129 | 1,129 | 1,101 | 1,107 | -21 | -1.9% | 199,000 |
2012/07/05 | 1,140 | 1,141 | 1,124 | 1,128 | +2 | +0.2% | 209,000 |
2012/07/04 | 1,133 | 1,133 | 1,122 | 1,126 | -5 | -0.4% | 234,000 |
2012/07/03 | 1,112 | 1,131 | 1,112 | 1,131 | +20 | +1.8% | 252,000 |
2012/07/02 | 1,124 | 1,127 | 1,111 | 1,111 | -7 | -0.6% | 202,000 |
2012/06/29 | 1,096 | 1,122 | 1,096 | 1,118 | +15 | +1.4% | 246,000 |
2012/06/28 | 1,093 | 1,107 | 1,093 | 1,103 | +5 | +0.5% | 241,000 |
2012/06/27 | 1,090 | 1,098 | 1,085 | 1,098 | +10 | +0.9% | 190,000 |
2012/06/26 | 1,086 | 1,106 | 1,086 | 1,088 | -3 | -0.3% | 297,000 |
2012/06/25 | 1,086 | 1,098 | 1,086 | 1,091 | -5 | -0.5% | 195,000 |
2012/06/22 | 1,082 | 1,099 | 1,078 | 1,096 | +10 | +0.9% | 321,000 |
2012/06/21 | 1,078 | 1,087 | 1,075 | 1,086 | +8 | +0.7% | 392,000 |
2012/06/20 | 1,080 | 1,085 | 1,077 | 1,078 | +15 | +1.4% | 322,000 |
2012/06/19 | 1,062 | 1,072 | 1,058 | 1,063 | +12 | +1.1% | 415,000 |
2012/06/18 | 1,048 | 1,056 | 1,048 | 1,051 | +10 | +1% | 285,000 |
3101~
3150
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 405,500円 | +30.5% | +111.0% | 4.69% | 11.43倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 381,000円 | +14.5% | -2.3% | 2.36% | 13.94倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 231,700円 | - | - | 0.00% | - | 107.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム